Human Papillomavirus Association and Genomic Exploration in Head-Neck Squamous Cell Carcinomas
NCT06642324 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2024-12-31
Summary
Head and neck squamous cell carcinoma (HNSCC) represents a significant public health burden in Bangladesh with a high incidence and mortality rate. While traditional risk factors like tobacco and betel nut chewing contribute to HNSCC incidence, the emergence of HPV-associated HNSCC presents a unique challenge. The main goal of this observational study is to explore the prevalence, risk factors, and biological mechanisms underlying food habits and HPV-driven HNSCC in the population and identify the genomic changes and characteristics related to this malignancy. This study will provide the prevalence of HPV-associated HNSCC and screening the HPV typing in the Bangladeshi population, identify risk factors, and any biologically driven mechanisms causing HNSCC.
Conditions
- Head Neck Cancer
- Oropharyngeal Neoplasms
Interventions
- DIAGNOSTIC_TEST
-
Histopathology, Immunohistochemistry, Real-Time PCR, Sequencing
Histopathology for carcinoma detection, Immunohistochemistry for carcinoma-related protein expression, Real-Time PCR for HPV association and HPV typing, Sequencing for genetic study or mutation analysis.
Sponsors & Collaborators
-
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
lead OTHER
Principal Investigators
-
S M Rashed Ul Islam, M. Phil, MPH · Bangabandhu Sheikh Mujib Medical University (BSMMU)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-30
- Primary Completion
- 2025-03-30
- Completion
- 2025-09-30
- FDA Device
- Yes
Countries
- Bangladesh
Study Locations
More Related Trials
-
Effects of Human Papillomavirus Diagnosis on Relationships of Patients With Head and Neck Cancer
NCT04666428 ·Status: COMPLETED
-
Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma
NCT05845632 ·Status: UNKNOWN
-
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753 ·Status: TERMINATED ·Phase: PHASE2
-
Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT00623558 ·Status: COMPLETED ·Phase: PHASE2
-
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
NCT06236464 ·Status: RECRUITING
-
A Randomised Controlled Trial Between Two Different HDR Brachytherapy Schedule in Locally Advanced Carcinoma of Uterine Cervix
NCT02765919 ·Status: COMPLETED ·Phase: PHASE3
-
WGA in Platinum-refractory HNSCC Underwent Nivolumab
NCT03917537 ·Status: UNKNOWN
-
Human Papillomavirus (HPV) in Squamous Cell Carcinoma of the Head and Neck
NCT01079546 ·Status: UNKNOWN
-
Study of Chemotherapy Prior to Radiotherapy and Chemotherapy in Patients With HPV Associated Cancer of the Oral Cavity
NCT01525927 ·Status: TERMINATED ·Phase: PHASE2
-
Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
NCT02277197 ·Status: COMPLETED ·Phase: PHASE1
-
Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma
NCT07127614 ·Status: NOT_YET_RECRUITING
-
PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
NCT03163797 ·Status: UNKNOWN
-
Expression of Programmed Death Ligand-1 (PD-L1) in Nasopharyngeal and Hyypopharyngeal Carcinoma
NCT05595265 ·Status: UNKNOWN
-
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NCT03396718 ·Status: RECRUITING ·Phase: NA
-
CD40 Agonist and PD-1 Inhibitor in HNSCC
NCT06159621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Imaging of Tumour Microenvironment in Patients With Oropharyngeal Head and Neck Squamous Cell Carcinoma Using RGD PET/CT Imaging
NCT04222543 ·Status: UNKNOWN ·Phase: PHASE2
-
De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell Carcinoma
NCT04638465 ·Status: ACTIVE_NOT_RECRUITING
-
Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
NCT02943044 ·Status: UNKNOWN
-
Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis
NCT02402348 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study
NCT02126189 ·Status: UNKNOWN
-
Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
NCT01958515 ·Status: COMPLETED
-
Expression & Epigenetic Silencing of MicroRNA for Predicting Therapeutic Response and Prognosis of HPV-negative HNSCC
NCT03953443 ·Status: COMPLETED
-
C-TPF in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT00402545 ·Status: COMPLETED ·Phase: PHASE1
-
Induction Chemotherapy Followed by Surgery for Locally Advanced Head and Neck Cancer
NCT02760667 ·Status: UNKNOWN ·Phase: PHASE2
-
Long-Term Impact of Human Papillomavirus (HPV) on Quality of Life
NCT01181648 ·Status: COMPLETED